| Literature DB >> 31402395 |
Karma Shiba Kyburz1, Theodore Eliades1, Spyridon N Papageorgiou2.
Abstract
BACKGROUND: The aim of the current systematic review was to compare the radiologic effects of functional appliance Class II treatment compared to no treatment on the temporomandibular joint and its components.Entities:
Keywords: Clinical trial; Functional appliance; Mandibular retrognathism; Orthodontics; Systematic review; Temporomandibular joint
Mesh:
Year: 2019 PMID: 31402395 PMCID: PMC6689567 DOI: 10.1186/s40510-019-0286-9
Source DB: PubMed Journal: Prog Orthod ISSN: 1723-7785 Impact factor: 2.750
Fig. 1PRISMA flow diagram for identification and selection of eligible trials
Characteristics of included studies
| Study | Design; setting; country$ | Patients (M/F); age* | Intervention; duration# | Follow-up | Imaging method | Outcome |
|---|---|---|---|---|---|---|
| Arat et al. [ | uNRS; Uni; TUR | CI. II/1; ANB ≥ 4°; SN-ML 25-32° EG, 9 (2/7); 11.2 CG, 9 (4/5); 9.7 | Activator; 16.0 | Pre-Tx 6.0 mos post-Tx (24.0 mos) | MRI | Condyle-to-disc angle (ant/mid/post) Joint space (anterior/posterior/medial) |
| Arici et al. [ | RCT; Uni; TUR | CI. II/1; OJ > 5 mm; Mnd RTG EG, 30 (13/17); NR CG, 30 (9/21); NR | FNFS; 7.0 | Pre-Tx Post-Tx (7.0 mos) | CT | COND volume GF volume Joint space volume (anterior/posterior) |
| Cevidanes et al. [ | RCT; Uni; USA | CI. II/1 ≥ ¾ unit; OJ > 4.5-10.0 mm EG, 28 (NR); 10.3 CG, 25 (NR); 10.9 | Fränkel-2; 18.0 | Pre-Tx Post-Tx (18.0 mos) | MRI | PCA of skeletal morphology |
| Chavan et al. [ | uNRS; Uni; IND | CI. II/1 EG1, 10 (6/4); 12.5 EG2, 10 (4/6); 11.5 CG, 10 (3/7); 12.0 | EG1: Twin Block EG2: Bionator | Pre-Tx 6.0 mos in Tx | MRI | SAG disc concentricity SAG disc position |
| Chintakanon and Chintakanon et al. [ | pNRS; pract; THA | CI. II/1; OJ > 5 mm; Mnd RTG EG, 19 (14/5); 11.7 CG, 21 (13/8); 11.5 | Twin Block; 6.0 | Pre-Tx 6.0 mos in Tx | MRI | Condylar axial angle Coronal disc position Eminence angle SAG disc concentricity SAG disc position |
| Croft et al. [ | rNRS; pract; USA | ANB ≥4°; Cl. II ≥ ½ unit EG, 40 (16/24); 8.5 CG†, 40; NR (matched) | RME/Herbst/EGA; 11.0 | Pre-Tx Post-Tx (11.0 mos) 2.7 years post-Tx | CT | Condylar growth GF displacement Joint space (anterior/posterior/superior) |
| Elfeky et al. [ | uNRS; Uni; EGY | Cl. II ≥ ½ unit; Mnd RTG; V-pattern EG, 22 (0/22); NR CG†, 18 (0/18); NR | Twin Block; 9.4 | Pre-Tx Post-Tx (9.4 mos) | CBCT | COND position COND size GF position Joint space (anterior/posterior/superior/medial) |
| Franco et al. and Franco [ | RCT; Uni; BRA | CI. II/1 EG, 28 (15/13); 10.3 CG, 28 (14/14); 10.9 | Fränkel-2; 18.0 | Pre-Tx Post-Tx (18.0 mos) | MRI | Disc position Disc shape |
CG control group, COND condyle, EG experimental group, EGA eruption guidance appliance, FA functional appliance (unspecified), FNFS Forsus nitinol flat-spring, GF glenoid fossa, M male, RCT randomized clinical trial, Mnd RTG mandibular retrognathism, NR not reported, PCA principal component analysis, pNRS prospective non-randomized study, Pract practice, rNRS retrospective non-randomized study, SAG sagittal, Uni university, V vertical, mos months
#Duration of active Class II treatment in months
$Countries are given with their ISO-3 code
*Age is given in years either as mean
†Historical
Risk of bias of the included randomized clinical trials with the Cochrane risk of bias tool
| Trial | Sequence generation | Allocation concealment | Blinding of participants/personnel | Blinding of outcome assessors | Incomplete outcome data | Selective outcome reporting | Other sources of bias |
|---|---|---|---|---|---|---|---|
| Arici et al. [ | Unclear—no randomization details provided information provided: “Thirty patients (17 girls, 13 boys) were randomly assigned to treatment with a fixed functional orthodontic appliance (Forsus nitinol flat-spring) for 6 to 9 months (mean, 7 months).” | Unclear—no information provided. | Unclear—blinding is impractical for both patients and clinician; outcome is objective, but was not assessed blindly. | High risk—no mention of blinding throughout the paper; blinding could have been implemented. | Low risk—no drop-outs or patient losses are reported. | Unclear—it is difficult to judge whether selective reporting is a problem, as no protocol exists. | Unclear—no definite issue identified (except for a possible confounder of vertical skeletal configuration type). |
| Cevidanes et al. [ | Unclear—no randomization details provided: “The Class II subjects were randomly allocated to 2 subgroups, treated and control, to avoid bias in the group comparison.” | Unclear—no information provided. | Low risk—blinding is impractical for both patients and clinician; outcome is objective and was assessed blindly. | Low risk—all images were coded and their order permutated to keep the analyst blind to subject identification group, and timing (T1 or T2). | Low risk—no drop-outs or patient losses are reported. | Unclear—it is difficult to judge whether selective reporting is a problem, as no protocol exists. | Unclear—no definite issue identified (except for a possible confounder of vertical skeletal configuration type). |
| Franco et al. and Franco [ | Unclear—no randomization details provided: “The sample was randomly dichotomized into 2 subgroups, treated subjects and untreated controls, to avoid bias in the group comparison.” | Unclear—no information provided. | Low risk—blinding is impractical for both patients and clinician; outcome is objective and was assessed blindly. | Unclear—blinding is mentioned: “A double-blind procedure was used”. However, no details are given and this is not mentioned at all in study published subsequently as dissertation. | Low risk—no drop-outs or patient losses are reported. | Unclear—it is difficult to judge whether selective reporting is a problem, as no protocol exists. | Unclear—no definite issue identified (except for a possible confounder of vertical skeletal configuration type). |
Fig. 2a Risk of bias summary for included randomized trials with the Cochrane risk of bias tool. b Risk of bias summary for included non-randomized trials with the ROBIN-I tool
Risk of bias of the included non-randomized clinical trials with the ROBINS-I tool
| Bias due to confounding | Bias in selection of participants into the study | Bias in classification of interventions | Bias due to deviations from intended interventions | Bias due to missing data | Bias in measurement of outcomes | Bias in selection of the reported result | Overall bias | |
|---|---|---|---|---|---|---|---|---|
| Arat et al. [ | Serious | No information | Low | No information | Low | Moderate | Low | Serious |
| Chavan et al. [ | Serious | Low | Low | No information | Low | Moderate | Low | Serious |
| Chintakanon and Chintakanon et al. [ | Serious | Low | Low | Moderate | Low | Moderate | Low | Serious |
| Croft 1999 [ | Critical | Serious | Low | Serious | Low | Moderate | Low | Critical |
| Elfeky et al. [ | Moderate | Serious | Low | No information | Moderate | Moderate | Low | Serious |
Results of random effects meta-analyses performed
| Treatment effects | Heterogeneity | |||||
|---|---|---|---|---|---|---|
| Outcome |
| MD (95% CI) |
| tau2 (95% CI) | 95% prediction | |
| Anterior joint space | 2 | − 0.72 (− 0.90, − 0.54) | < 0.001 | 0 (0, 2.25) | 4% (0%, 99%) | NC |
| Posterior joint space | 2 | 1.03 (0.87, 1.19) | < 0.001 | 0 (0, 1.41) | 0% (0%, 98%) | NC |
| Superior joint space | 2 | 0.72 (0.48, 0.96) | < 0.001 | 0 (0, 3.92) | 0% (0%, 99%) | NC |
| Anterior angle | 2 | 0.57 (− 3.90, 5.03) | 0.80 | 4.71 (NC) | 45% (NC) | NC |
| Posterior angle | 3 | − 7.28 (− 16.67, 1.11) | 0.09 | 47.61 (7.23, 921.80) | 90% (7%, 99%) | − 110.45, 95.90 |
| Condylar coronary width | 2 | 1.12 (0.06 2.19) | 0.04 | 0.50 (0, 75.91) | 83% (0%, 100%) | NC |
| Glenoid fossa sagittal displacement | 2 | − 0.30 (− 0.74, 0.14) | 0.18 | 0.01 (0, 12.63) | 11% (0%, 99%) | NC |
| Glenoid fossa vertical displacement | 2 | − 0.39 (− 0.70, − 0.08) | 0.01 | 0 (0, 5.027) | 0% (0%, 99%) | NC |
| Sagittal concentricity | 2 | 1.29 (− 22.33, 24.91) | 0.92 | 288.29 (NC) | 99% (NC) | NC |
CI confidence interval, MD mean difference, NC noncalculable
Fig. 3Contour-enhanced forest plots for random effects meta-analyses comparing functional appliance treatment to no treatment (observation) in terms of changes in a anterior joint space, b posterior joint space, c superior joint space, d anterior angle, and e posterior angle
Fig. 4Contour-enhanced forest plots for random effects meta-analyses comparing functional appliance treatment to no treatment (observation) in terms of changes in a condylar coronary width, b glenoid fossa sagittal displacement, c glenoid fossa vertical displacement, and d sagittal concentricity. CI, confidence interval; MD, mean difference
Summary of findings table according to the GRADE approach
| Anticipated absolute effects (95% CI) | |||||
|---|---|---|---|---|---|
| Outcome (follow-up) | Controla | FA | Difference with FA | Quality of the evidence (GRADE)b | What happens with FAs |
Anterior joint space (6.0–9.4 mos) 54 patients (2 studies) | < 0.1 mm | – | 0.7 mm smaller (0.5 to 0.9 smaller) | ⊕◯⃝⃝ very lowc Due to bias | Might shrink anterior joint space |
Posterior joint space (6.0–9.4 mos) 54 patients (2 studies) | − 0.1 mm | – | 1.0 mm larger (0.9 to 1.2 larger) | ⊕◯⃝⃝ very lowc Due to bias | Might enlarge posterior joint space |
Superior joint space (6.0–9.4 mos) 54 patients (2 studies) | − 0.2 mm | – | 0.7 mm larger (0.5 to 1.0 larger) | ⊕◯⃝⃝ very lowc Due to bias | Might enlarge superior joint space |
Anterior angle (6.0 mos) 58 patients (2 studies) | − 0.8° | – | 0.6° larger (3.9 smaller to 5.0 larger) | ⊕◯⃝⃝ very lowc, d Due to bias, imprecision | Little to no difference in anterior angle |
Posterior angle (6.0 mos) 88 patients (3 studies) | − 1.4° | – | 7.3° smaller (16.7 smaller to 1.1 larger) | ⊕◯⃝⃝ very lowc, d Due to bias, imprecision | Little to no difference in posterior angle |
Condylar coronary width (6.0–9.4 mos) 76 patients (2 studies) | − 0.1 mm | – | 1.1 mm wider (0.1 to 2.2 wider) | ⊕◯⃝⃝ very lowc, d Due to bias, imprecision | Might increase condylar coronary width |
GleFo sagittal displacement (9.4–11.0 mos) 164 patients (2 studies) | − 0.9 mm (posterior) | – | 0.3 mm more posterior (0.7 less to 0.1 more) | ⊕◯⃝⃝ very lowc Due to bias | Little to no difference in glenoid fossa sagittal displacement |
GleFo vertical displacement (9.4–11.0 mos) 164 patients (2 studies) | 0.7 mm (superior) | – | 0.4 mm more inferior (0.7 to 0.1 more) | ⊕◯⃝⃝ very lowc Due to bias | Little to no difference in glenoid fossa vertical displacement |
Sagittal concentricity index (6.0–18.0 mos) 86 patients (2 studies) | 1.3% | – | 1.3% greater (22.3 smaller to 24.9 greater) | ⊕◯⃝⃝ very lowc, d, e Due to bias, imprecision, inconsistency | Little to no difference in sagittal concentricity |
Intervention: functional appliance treatment (Activator, Bionator, Forsus Nitinol Flat-Spring, Fränkel, Herbst, Twin Block) versus control (observation)/population: Class II adolescent patients/setting: university clinics, private practice (Brazil, Egypt, India, Thailand, Turkey, USA)
CI confidence interval, FA functional appliance, GleFo glenoid fossa, GRADE Grading of Recommendations Assessment, Development and Evaluation, mos months
aResponse in the control group is based on average response of included studies
bStarts from “low,” due to the inclusion of randomized studies
cDowngraded by one point for risk of bias (serious/critical risk of bias due to methodological limitations)
dDowngraded by one point due to imprecision, as the optimal information size was judged not to be met and/or the summary estimate was strewn across different categories of effect magnitude
eDowngraded one for inconsistency (I2 > 75%), which can affect our decision about the treatment effects